0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A mouse model to distinguish NLRP6-mediated inflammasome-dependent and -independent functions

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance

          NLRP6 is an IEC-specific NLR that senses microbial dsRNA and LTA, which mediates inflammasome and type I IFN activation and may regulate NF-κB and MAPK pathways. Previous studies used complete knock-out of NLRP6 in mice to study its in vivo function, which cannot distinguish the multiple pathways mediated by NLRP6. Here, we generated a mutant mouse model by knocking in the R39E and W50E mutations to specifically block NLRP6-mediated inflammasome activation, which could distinguish inflammasome-dependent and -independent functions of NLRP6 in vivo.

          Abstract

          The NOD-like receptor (NLR) family pyrin domain containing 6 (NLRP6) serves as a sensor for microbial dsRNA or lipoteichoic acid (LTA) in intestinal epithelial cells (IECs), and initiating multiple pathways including inflammasome pathway and type I interferon (IFN) pathway, or regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) pathways. NLRP6 can exert its function in both inflammasome-dependent and inflammasome-independent manners. However, there is no tool to distinguish the contribution of individual NLRP6-mediated pathway to the physiology and pathology in vivo. Here, we validated that Arg39 and Trp50 residues in the pyrin domain (PYD) of murine NLRP6 are required for ASC recruitment and inflammasome activation, but are not important for the RNA binding and PYD-independent NLRP6 oligomerization. We further generated the Nlrp6 R39E&W50E mutant mice, which showed reduced inflammasome activation in either steady state intestine or during viral infection. However, the type I IFN production in cells or intestine tissue from Nlrp6 R39E&W50E mutant mice remain normal. Interestingly, NLRP6-mediated inflammasome activation or the IFN-I production seems to play distinct roles in the defense responses against different types of RNA viruses. Our work generated a useful tool to study the inflammasome-dependent role of NLRP6 in vivo, which might help to understand the complexity of multiple pathways mediated by NLRP6 in response to the complicated and dynamic environmental cues in the intestine.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: not found

          Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses.

          The innate immune system senses viral infection by recognizing a variety of viral components (including double-stranded (ds)RNA) and triggers antiviral responses. The cytoplasmic helicase proteins RIG-I (retinoic-acid-inducible protein I, also known as Ddx58) and MDA5 (melanoma-differentiation-associated gene 5, also known as Ifih1 or Helicard) have been implicated in viral dsRNA recognition. In vitro studies suggest that both RIG-I and MDA5 detect RNA viruses and polyinosine-polycytidylic acid (poly(I:C)), a synthetic dsRNA analogue. Although a critical role for RIG-I in the recognition of several RNA viruses has been clarified, the functional role of MDA5 and the relationship between these dsRNA detectors in vivo are yet to be determined. Here we use mice deficient in MDA5 (MDA5-/-) to show that MDA5 and RIG-I recognize different types of dsRNAs: MDA5 recognizes poly(I:C), and RIG-I detects in vitro transcribed dsRNAs. RNA viruses are also differentially recognized by RIG-I and MDA5. We find that RIG-I is essential for the production of interferons in response to RNA viruses including paramyxoviruses, influenza virus and Japanese encephalitis virus, whereas MDA5 is critical for picornavirus detection. Furthermore, RIG-I-/- and MDA5-/- mice are highly susceptible to infection with these respective RNA viruses compared to control mice. Together, our data show that RIG-I and MDA5 distinguish different RNA viruses and are critical for host antiviral responses.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling.

            Host-microbiome co-evolution drives homeostasis and disease susceptibility, yet regulatory principles governing the integrated intestinal host-commensal microenvironment remain obscure. While inflammasome signaling participates in these interactions, its activators and microbiome-modulating mechanisms are unknown. Here, we demonstrate that the microbiota-associated metabolites taurine, histamine, and spermine shape the host-microbiome interface by co-modulating NLRP6 inflammasome signaling, epithelial IL-18 secretion, and downstream anti-microbial peptide (AMP) profiles. Distortion of this balanced AMP landscape by inflammasome deficiency drives dysbiosis development. Upon fecal transfer, colitis-inducing microbiota hijacks this microenvironment-orchestrating machinery through metabolite-mediated inflammasome suppression, leading to distorted AMP balance favoring its preferential colonization. Restoration of the metabolite-inflammasome-AMP axis reinstates a normal microbiota and ameliorates colitis. Together, we identify microbial modulators of the NLRP6 inflammasome and highlight mechanisms by which microbiome-host interactions cooperatively drive microbial community stability through metabolite-mediated innate immune modulation. Therefore, targeted "postbiotic" metabolomic intervention may restore a normal microenvironment as treatment or prevention of dysbiosis-driven diseases.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Interferon-Stimulated Genes: What Do They All Do?

              In the absence of an intact interferon (IFN) response, mammals may be susceptible to lethal viral infection. IFNs are secreted cytokines that activate a signal transduction cascade leading to the induction of hundreds of interferon-stimulated genes (ISGs). Remarkably, approximately 10% of the genes in the human genome have the potential to be regulated by IFNs. What do all of these genes do? It is a complex question without a simple answer. From decades of research, we know that many of the protein products encoded by these ISGs work alone or in concert to achieve one or more cellular outcomes, including cell intrinsic antiviral defense, antiproliferative activities, and stimulation of adaptive immunity. The focus of this review is the antiviral activities of the IFN/ISG system. This includes general paradigms of ISG function, supported by specific examples in the literature, as well as methodologies to identify and characterize ISG function. Expected final online publication date for the Annual Review of Virology Volume 6 is September 30, 2019. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.
                Bookmark

                Author and article information

                Contributors
                Journal
                Proc Natl Acad Sci U S A
                Proc Natl Acad Sci U S A
                PNAS
                Proceedings of the National Academy of Sciences of the United States of America
                National Academy of Sciences
                0027-8424
                1091-6490
                30 January 2024
                6 February 2024
                30 July 2024
                : 121
                : 6
                : e2321419121
                Affiliations
                [1] aDepartment of Digestive Disease, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei 230001, China
                [2] bInstitute of Immunology and the Chinese Academy of Sciences Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei 230027, China
                [3] cInstitute of Health and Medicine, Hefei Comprehensive National Science Center , Hefei 230051, China
                [4] dDepartment of Molecular Microbiology, Washington University School of Medicine , Saint Louis, MO 63110
                [5] eDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine , Saint Louis, MO 63110
                [6] fDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School , Boston, MA 02115
                [7] gProgram in Cellular and Molecular Medicine , Boston Children’s Hospital, Boston, MA 02115
                Author notes
                2To whom correspondence may be addressed. Email: shenc@ 123456wustl.edu , wu@ 123456crystal.harvard.edu , or zhushu@ 123456ustc.edu.cn .

                Contributed by Hao Wu; received December 6, 2023; accepted December 28, 2023; reviewed by Bo Hu and Jie Zheng

                1R.L. and Y.Z. contributed equally to this work.

                Author information
                https://orcid.org/0000-0002-5338-260X
                https://orcid.org/0000-0002-7281-8579
                https://orcid.org/0000-0002-8163-0869
                Article
                202321419
                10.1073/pnas.2321419121
                10861855
                38289959
                c8d3132f-5e5f-416a-baaf-3395d76351a5
                Copyright © 2024 the Author(s). Published by PNAS.

                This article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).

                History
                : 06 December 2023
                : 28 December 2023
                Page count
                Pages: 9, Words: 5209
                Funding
                Funded by: National Natural Science Foundation of China;
                Award ID: 82325025
                Award Recipient : Shu Zhu
                Funded by: Chinese Academy of Sciences (CAS), FundRef 501100002367;
                Award ID: YSBR-074
                Award Recipient : Shu Zhu
                Categories
                research-article, Research Article
                immun, Immunology and Inflammation
                420
                Biological Sciences
                Immunology and Inflammation

                nlrp6,inflammasome,interferon,rna virus,r39/w50 mutations
                nlrp6, inflammasome, interferon, rna virus, r39/w50 mutations

                Comments

                Comment on this article